Even H Rustad
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 19
- Multiple Myeloma Research and Treatments 19
-
- Protein Degradation and Inhibitors 6
- Glycosylation and Glycoproteins Research 5
- Co-authors
- Ola Landgren (14 shared papers)Francesco Maura (8 shared papers)Malin Hultcrantz (10 shared papers)Niccolò Bolli (5 shared papers)Gareth J. Morgan (4 shared papers)Eileen M. Boyle (3 shared papers)Kylee Maclachlan (4 shared papers)Bachisio Ziccheddu (3 shared papers)
- Journals
- Blood (8 papers)Best Practice & Research Clinical Haematology (2 papers)Communications Biology (1 paper)Nature Communications (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- United StatesNorwayItaly
In The Last Decade
Even H Rustad
22 papers receiving 330 citations
Peers
Comparison fields: 5 of 35
- Hematology 253
- Oncology 100
- Molecular Biology 213
- Cancer Research 37
- Genetics 19
Countries citing papers authored by Even H Rustad
This map shows the geographic impact of Even H Rustad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Even H Rustad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Even H Rustad more than expected).
Fields of papers citing papers by Even H Rustad
This network shows the impact of papers produced by Even H Rustad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Even H Rustad. The network helps show where Even H Rustad may publish in the future.
Co-authors
The 25 scholars most cited alongside Even H Rustad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 50 | |
| 2 | 2020 | 38 | |
| 3 | 2022 | 37 | |
| 4 | 2021 | 30 | |
| 5 | 2021 | 28 | |
| 6 | 2019 | 25 | |
| 7 | 2023 | 20 | |
| 8 | 2020 | 19 | |
| 9 | 2020 | 18 | |
| 10 | 2021 | 18 | |
| 11 | 2018 | 17 | |
| 12 | 2024 | 8 | |
| 13 | 2020 | 8 | |
| 14 | 2019 | 4 | |
| 15 | 2018 | 3 | |
| 16 | 2020 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2018 | 1 |
About Even H Rustad
Even H Rustad is a scholar working on Hematology, Molecular Biology, Cancer Research, Oncology and Immunology, having authored 23 papers that have together received 331 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (6 papers), Glycosylation and Glycoproteins Research (5 papers), Cancer Genomics and Diagnostics (4 papers), Immunotherapy and Immune Responses (2 papers), Malaria Research and Control (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Hematology (253 citations), Oncology (100 citations), Molecular Biology (213 citations), Cancer Research (37 citations) and Genetics (19 citations). Even H Rustad has collaborated with scholars based in United States, Norway and Italy. Frequent co-authors include Ola Landgren, Francesco Maura, Malin Hultcrantz, Niccolò Bolli, Gareth J. Morgan, Eileen M. Boyle, Kylee Maclachlan, Bachisio Ziccheddu, Mikhail Roshal and Katie Thoren. Their work appears in journals such as Blood, Best Practice & Research Clinical Haematology, Communications Biology, Nature Communications and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.